Global /South Korea /Healthcare /Medical Devices /468530

Proteina Co., Ltd.

468530

• KRX: 468530 • Delayed

56,400KRW -7.8%

36.79 USD

As of 5 June 2026, Proteina Co., Ltd. has a market cap of $436.77M USD, ranking #16103 globally and #493 in South Korea. It ranks #1447 in the Healthcare sector, and #308 in the Medical Devices industry.

Global Rank

16103

Country Rank

493

Sector Rank

1447

Industry Rank

308

Key Stats

Market Cap

$436.77MUSD

669.5B KRW

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Medical Devices

CEO

Tae-Young Yoon open_in_new

Founded

2015

Website

proteina.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-7.8%	2.9%	-20%	-24%	14%	-45%	59%	59%	59%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	468530 ISIN: KR7468530001 Shares Out.: Shares Outstanding: 11.035M¹ Shares Float: 6.049M² TV: TradingView: KRX: 468530 SA: Stock Analysis: KRX: 468530 YF: Yahoo Finance: 468530.KS GF: Google Finance: KRX: 468530 BA: Barron's: 468530 MS: Morningstar: XKRX: 468530	56,400 KRW	TV: TradingView: KRX: 468530 SA: Stock Analysis: KRX: 468530 YF: Yahoo Finance: 468530.KS GF: Google Finance: KRX: 468530 BA: Barron's: 468530 MS: Morningstar: XKRX: 468530

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Proteina Co., Ltd.

Proteina Co.,Ltd. develops protein-protein interaction profiling technology. The company offers technology that confirms the real-time activation of cancer signal pathways by directly seeing the relevant proteins, predicts the efficacy of drugs, and enables doctors to select which inhibitor to prescribe by confirming which bypass signal pathways are inducing resistance. It also offers single molecule protein interaction detection platform to analyze protein and protein-protein interaction (PPI) information. Proteina Co., Ltd. was founded in 2015 and is based in Seoul, South Korea.

Similar Companies

Industry: Medical Devices (South Korea)

Name	Market Cap (USD) diff.	PE	Country
CLASSYS Inc. KRX: 214150	$2.45B 3.75T KRW 460%	28.7	South Korea
SEERS Co., Ltd. KRX: 458870	$1.22B 1.86T KRW 179%	114.8	South Korea
Livsmed Inc. KRX: 491000	$1.18B 1.81T KRW 170%	-	South Korea
L&C BIO Co.,LTD KRX: 290650	$1.13B 1.74T KRW 159%	-	South Korea
Seegene, Inc. KRX: 096530	$753.63M 1.16T KRW 73%	23.9	South Korea
i3system Inc. KRX: 214430	$528.2M 809.64B KRW 21%	83.3	South Korea

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 40K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 37K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 36K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 29K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 28K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 23K%	22.2	Ireland

chevron_leftBack